ID   IP6K2_HUMAN             Reviewed;         426 AA.
AC   Q9UHH9; A8K3B1; B4E3G6; G8JLL6; Q6P0N8; Q9BSZ6; Q9BUW3; Q9H4P7; Q9NT63;
AC   Q9UFU6;
DT   19-JUL-2004, integrated into UniProtKB/Swiss-Prot.
DT   19-JUL-2004, sequence version 2.
DT   28-JUN-2023, entry version 175.
DE   RecName: Full=Inositol hexakisphosphate kinase 2;
DE            Short=InsP6 kinase 2 {ECO:0000303|PubMed:10574768};
DE            Short=InsP6K2 {ECO:0000303|PubMed:11502751};
DE            EC=2.7.4.- {ECO:0000269|PubMed:10574768, ECO:0000269|PubMed:30624931};
DE   AltName: Full=P(i)-uptake stimulator;
DE            Short=PiUS {ECO:0000303|PubMed:10574768};
GN   Name=IP6K2 {ECO:0000303|PubMed:30624931}; Synonyms=IHPK2;
GN   ORFNames=TCCCIA00113;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, CATALYTIC ACTIVITY, AND
RP   BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=10574768; DOI=10.1016/s0960-9822(00)80055-x;
RA   Saiardi A., Erdjument-Bromage H., Snowman A.M., Tempst P., Snyder S.H.;
RT   "Synthesis of diphosphoinositol pentakisphosphate by a newly identified
RT   family of higher inositol polyphosphate kinases.";
RL   Curr. Biol. 9:1323-1326(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Leukemia;
RA   Zhou J., Yu W., Tang H., Mei G., Tsang Y.T.M., Bouck J., Gibbs R.A.,
RA   Margolin J.F.;
RT   "Pediatric leukemia cDNA sequencing project.";
RL   Submitted (JUL-2000) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 4 AND 5).
RC   TISSUE=Brain, and Uterus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R., Buhay C.J.,
RA   Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P.,
RA   Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V., Hume J., Jackson A.,
RA   Khan Z.M., Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Morgan M.B., Nazareth L.V., Scott G.,
RA   Sodergren E., Song X.-Z., Steffen D., Wei S., Wheeler D.A., Wright M.W.,
RA   Worley K.C., Yuan Y., Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M.,
RA   Brown M.J., Chen G., Chen Z., Clendenning J., Clerc-Blankenburg K.P.,
RA   Chen R., Chen Z., Davis C., Delgado O., Dinh H.H., Dong W., Draper H.,
RA   Ernst S., Fu G., Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J.,
RA   Hao B., Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W.,
RA   Jackson L.R., Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B.,
RA   Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O.,
RA   Palmeiri A., Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J., Zhang X.,
RA   Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H., Reinhardt R.,
RA   Naylor S.L., Yang H., Olson M., Weinstock G., Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2; 3 AND 6).
RC   TISSUE=Brain, Lung, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 76-426 (ISOFORMS 1 AND 2).
RC   TISSUE=Uterus;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [7]
RP   SUBCELLULAR LOCATION.
RX   PubMed=11502751; DOI=10.1074/jbc.m106842200;
RA   Saiardi A., Nagata E., Luo H.R., Snowman A.M., Snyder S.H.;
RT   "Identification and characterization of a novel inositol hexakisphosphate
RT   kinase.";
RL   J. Biol. Chem. 276:39179-39185(2001).
RN   [8]
RP   FUNCTION, CATALYTIC ACTIVITY, AND ACTIVITY REGULATION.
RX   PubMed=30624931; DOI=10.1021/acs.jmedchem.8b01593;
RA   Gu C., Stashko M.A., Puhl-Rubio A.C., Chakraborty M., Chakraborty A.,
RA   Frye S.V., Pearce K.H., Wang X., Shears S.B., Wang H.;
RT   "Inhibition of Inositol Polyphosphate Kinases by Quercetin and Related
RT   Flavonoids: A Structure-Activity Analysis.";
RL   J. Med. Chem. 62:1443-1454(2019).
CC   -!- FUNCTION: Converts inositol hexakisphosphate (InsP6) to
CC       diphosphoinositol pentakisphosphate (InsP7/PP-InsP5).
CC       {ECO:0000269|PubMed:10574768, ECO:0000269|PubMed:30624931}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1D-myo-inositol hexakisphosphate + ATP = 5-diphospho-1D-myo-
CC         inositol 1,2,3,4,6-pentakisphosphate + ADP; Xref=Rhea:RHEA:12793,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:58130, ChEBI:CHEBI:58628,
CC         ChEBI:CHEBI:456216; Evidence={ECO:0000269|PubMed:10574768,
CC         ECO:0000269|PubMed:30624931};
CC   -!- ACTIVITY REGULATION: Inhibited by flavonoids, including myricetin,
CC       quercetin, luteolin, isorhamnetin, rhamnetin, kaempferol, diosmetin and
CC       apigenin. {ECO:0000269|PubMed:30624931}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=3 uM for inositol hexakisphosphate {ECO:0000269|PubMed:10574768};
CC         KM=1 mM for ATP {ECO:0000269|PubMed:10574768};
CC         Vmax=2 umol/min/mg enzyme {ECO:0000269|PubMed:10574768};
CC   -!- PATHWAY: Phospholipid metabolism; phosphatidylinositol metabolism.
CC       {ECO:0000269|PubMed:10574768, ECO:0000269|PubMed:30624931}.
CC   -!- INTERACTION:
CC       Q9UHH9; P07900: HSP90AA1; NbExp=2; IntAct=EBI-747509, EBI-296047;
CC       Q9UHH9; Q8N448: LNX2; NbExp=3; IntAct=EBI-747509, EBI-2340947;
CC       Q9UHH9; P50222: MEOX2; NbExp=3; IntAct=EBI-747509, EBI-748397;
CC       Q9UHH9; O60568: PLOD3; NbExp=3; IntAct=EBI-747509, EBI-741582;
CC       Q9UHH9; Q93062: RBPMS; NbExp=3; IntAct=EBI-747509, EBI-740322;
CC       Q9UHH9; P04637: TP53; NbExp=4; IntAct=EBI-747509, EBI-366083;
CC       Q9UHH9; Q8N680: ZBTB2; NbExp=3; IntAct=EBI-747509, EBI-2515601;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11502751}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC       Name=1;
CC         IsoId=Q9UHH9-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UHH9-2; Sequence=VSP_010925, VSP_010928;
CC       Name=3;
CC         IsoId=Q9UHH9-3; Sequence=VSP_010926, VSP_010927;
CC       Name=4;
CC         IsoId=Q9UHH9-4; Sequence=VSP_042698, VSP_042699, VSP_042700;
CC       Name=5;
CC         IsoId=Q9UHH9-5; Sequence=VSP_042845, VSP_042699, VSP_042700;
CC       Name=6;
CC         IsoId=Q9UHH9-6; Sequence=VSP_045416, VSP_045417;
CC   -!- MISCELLANEOUS: [Isoform 3]: May be produced at very low levels due to a
CC       premature stop codon in the mRNA, leading to nonsense-mediated mRNA
CC       decay. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the inositol phosphokinase (IPK) family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF177145; AAF15057.1; -; mRNA.
DR   EMBL; AY007091; AAG01984.1; -; mRNA.
DR   EMBL; AK290526; BAF83215.1; -; mRNA.
DR   EMBL; AK304714; BAG65478.1; -; mRNA.
DR   EMBL; AC141002; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC001864; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; BC004469; AAH04469.2; -; mRNA.
DR   EMBL; BC019694; AAH19694.1; -; mRNA.
DR   EMBL; BC065533; AAH65533.1; -; mRNA.
DR   EMBL; CA488567; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AL117458; CAB55936.1; -; mRNA.
DR   EMBL; AL137514; CAB70780.1; -; mRNA.
DR   CCDS; CCDS2777.1; -. [Q9UHH9-1]
DR   CCDS; CCDS33752.1; -. [Q9UHH9-2]
DR   CCDS; CCDS54579.1; -. [Q9UHH9-6]
DR   CCDS; CCDS54580.1; -. [Q9UHH9-4]
DR   CCDS; CCDS54581.1; -. [Q9UHH9-5]
DR   PIR; T17246; T17246.
DR   PIR; T46275; T46275.
DR   RefSeq; NP_001005909.1; NM_001005909.2. [Q9UHH9-1]
DR   RefSeq; NP_001005910.1; NM_001005910.2. [Q9UHH9-2]
DR   RefSeq; NP_001005911.1; NM_001005911.2. [Q9UHH9-2]
DR   RefSeq; NP_001139650.1; NM_001146178.2. [Q9UHH9-6]
DR   RefSeq; NP_001139651.1; NM_001146179.2. [Q9UHH9-6]
DR   RefSeq; NP_001177245.1; NM_001190316.1. [Q9UHH9-4]
DR   RefSeq; NP_001177246.1; NM_001190317.1. [Q9UHH9-5]
DR   RefSeq; NP_057375.2; NM_016291.3. [Q9UHH9-1]
DR   RefSeq; XP_011532124.1; XM_011533822.1.
DR   RefSeq; XP_011532125.1; XM_011533823.1.
DR   RefSeq; XP_016862072.1; XM_017006583.1.
DR   RefSeq; XP_016862073.1; XM_017006584.1.
DR   RefSeq; XP_016862074.1; XM_017006585.1.
DR   AlphaFoldDB; Q9UHH9; -.
DR   BioGRID; 119546; 24.
DR   DIP; DIP-29676N; -.
DR   IntAct; Q9UHH9; 12.
DR   MINT; Q9UHH9; -.
DR   STRING; 9606.ENSP00000331103; -.
DR   BindingDB; Q9UHH9; -.
DR   ChEMBL; CHEMBL4523488; -.
DR   GlyGen; Q9UHH9; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q9UHH9; -.
DR   PhosphoSitePlus; Q9UHH9; -.
DR   BioMuta; IP6K2; -.
DR   DMDM; 50400688; -.
DR   EPD; Q9UHH9; -.
DR   MassIVE; Q9UHH9; -.
DR   MaxQB; Q9UHH9; -.
DR   PaxDb; Q9UHH9; -.
DR   PeptideAtlas; Q9UHH9; -.
DR   ProteomicsDB; 34267; -.
DR   ProteomicsDB; 84351; -. [Q9UHH9-1]
DR   ProteomicsDB; 84352; -. [Q9UHH9-2]
DR   ProteomicsDB; 84353; -. [Q9UHH9-3]
DR   ProteomicsDB; 84354; -. [Q9UHH9-4]
DR   ProteomicsDB; 84355; -. [Q9UHH9-5]
DR   Antibodypedia; 1556; 244 antibodies from 31 providers.
DR   DNASU; 51447; -.
DR   Ensembl; ENST00000328631.10; ENSP00000331103.5; ENSG00000068745.15. [Q9UHH9-1]
DR   Ensembl; ENST00000340879.8; ENSP00000341925.4; ENSG00000068745.15. [Q9UHH9-2]
DR   Ensembl; ENST00000413298.5; ENSP00000396203.1; ENSG00000068745.15. [Q9UHH9-2]
DR   Ensembl; ENST00000416707.1; ENSP00000387759.1; ENSG00000068745.15. [Q9UHH9-3]
DR   Ensembl; ENST00000431721.6; ENSP00000414139.2; ENSG00000068745.15. [Q9UHH9-4]
DR   Ensembl; ENST00000432678.6; ENSP00000400812.2; ENSG00000068745.15. [Q9UHH9-6]
DR   Ensembl; ENST00000446860.5; ENSP00000399052.1; ENSG00000068745.15. [Q9UHH9-5]
DR   GeneID; 51447; -.
DR   KEGG; hsa:51447; -.
DR   MANE-Select; ENST00000328631.10; ENSP00000331103.5; NM_016291.4; NP_057375.2.
DR   UCSC; uc003cuq.4; human. [Q9UHH9-1]
DR   AGR; HGNC:17313; -.
DR   CTD; 51447; -.
DR   DisGeNET; 51447; -.
DR   GeneCards; IP6K2; -.
DR   HGNC; HGNC:17313; IP6K2.
DR   HPA; ENSG00000068745; Low tissue specificity.
DR   MIM; 606992; gene.
DR   neXtProt; NX_Q9UHH9; -.
DR   OpenTargets; ENSG00000068745; -.
DR   PharmGKB; PA164720999; -.
DR   VEuPathDB; HostDB:ENSG00000068745; -.
DR   eggNOG; KOG1620; Eukaryota.
DR   GeneTree; ENSGT00940000156310; -.
DR   HOGENOM; CLU_014862_0_0_1; -.
DR   InParanoid; Q9UHH9; -.
DR   OMA; SDCEPKN; -.
DR   OrthoDB; 20436at2759; -.
DR   PhylomeDB; Q9UHH9; -.
DR   TreeFam; TF314066; -.
DR   BioCyc; MetaCyc:HS00942-MON; -.
DR   BRENDA; 2.7.4.21; 2681.
DR   PathwayCommons; Q9UHH9; -.
DR   Reactome; R-HSA-1855191; Synthesis of IPs in the nucleus.
DR   Reactome; R-HSA-909733; Interferon alpha/beta signaling.
DR   SABIO-RK; Q9UHH9; -.
DR   SignaLink; Q9UHH9; -.
DR   UniPathway; UPA00949; -.
DR   BioGRID-ORCS; 51447; 8 hits in 1158 CRISPR screens.
DR   ChiTaRS; IP6K2; human.
DR   GeneWiki; IHPK2; -.
DR   GenomeRNAi; 51447; -.
DR   Pharos; Q9UHH9; Tbio.
DR   PRO; PR:Q9UHH9; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   RNAct; Q9UHH9; protein.
DR   Bgee; ENSG00000068745; Expressed in right hemisphere of cerebellum and 187 other tissues.
DR   ExpressionAtlas; Q9UHH9; baseline and differential.
DR   Genevisible; Q9UHH9; HS.
DR   GO; GO:0030054; C:cell junction; IDA:HPA.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0001650; C:fibrillar center; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0097243; F:flavonoid binding; IDA:UniProtKB.
DR   GO; GO:0052836; F:inositol 5-diphosphate pentakisphosphate 5-kinase activity; TAS:Reactome.
DR   GO; GO:0052839; F:inositol diphosphate tetrakisphosphate kinase activity; TAS:Reactome.
DR   GO; GO:0000829; F:inositol heptakisphosphate kinase activity; TAS:Reactome.
DR   GO; GO:0000832; F:inositol hexakisphosphate 5-kinase activity; IDA:UniProtKB.
DR   GO; GO:0000828; F:inositol hexakisphosphate kinase activity; IDA:UniProtKB.
DR   GO; GO:0000827; F:inositol-1,3,4,5,6-pentakisphosphate kinase activity; TAS:Reactome.
DR   GO; GO:1905396; P:cellular response to flavonoid; IMP:UniProtKB.
DR   GO; GO:0032958; P:inositol phosphate biosynthetic process; IBA:GO_Central.
DR   GO; GO:0043647; P:inositol phosphate metabolic process; IDA:UniProtKB.
DR   GO; GO:0030308; P:negative regulation of cell growth; IMP:UniProtKB.
DR   GO; GO:0006817; P:phosphate ion transport; IEA:Ensembl.
DR   GO; GO:0046854; P:phosphatidylinositol phosphate biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0016310; P:phosphorylation; IEA:UniProtKB-KW.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IMP:UniProtKB.
DR   GO; GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IEA:Ensembl.
DR   GO; GO:0050821; P:protein stabilization; IEA:Ensembl.
DR   Gene3D; 3.30.470.160; Inositol polyphosphate kinase; 1.
DR   InterPro; IPR005522; IPK.
DR   InterPro; IPR038286; IPK_sf.
DR   PANTHER; PTHR12400:SF47; INOSITOL HEXAKISPHOSPHATE KINASE 2; 1.
DR   PANTHER; PTHR12400; INOSITOL POLYPHOSPHATE KINASE; 1.
DR   Pfam; PF03770; IPK; 1.
DR   SUPFAM; SSF56104; SAICAR synthase-like; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Kinase; Lipid metabolism;
KW   Nucleotide-binding; Nucleus; Phospholipid metabolism; Reference proteome;
KW   Transferase.
FT   CHAIN           1..426
FT                   /note="Inositol hexakisphosphate kinase 2"
FT                   /id="PRO_0000066877"
FT   BINDING         207..209
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q8NFU5"
FT   BINDING         220
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q8NFU5"
FT   BINDING         222
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:Q8NFU5"
FT   BINDING         236..243
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:Q8NFU5"
FT   BINDING         383
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q8NFU5"
FT   BINDING         386
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:Q8NFU5"
FT   VAR_SEQ         1
FT                   /note="M -> MSLNLPEASLLSRASWPEQAKEPRREGHTDKQQTEDVLAAGLRCLPH
FT                   LPAICARRM (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_042698"
FT   VAR_SEQ         1
FT                   /note="M -> MNLCQSPFQEGCQSLLASWPEQAKEPRREGHTDKQQTEDVLAAGLRC
FT                   LPHLPAICARRM (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_042845"
FT   VAR_SEQ         69..130
FT                   /note="VVSVRFEEDEDRNLCLIAYPLKGDHGIVDIVDNSDCEPKSKLLRWTTNKKHH
FT                   VLETEKTPKD -> KSQLLEGLPHWRGDVRDRGHGRPWQPSLEPSLPPTLCFPSLSSFS
FT                   SSWPSAQHLTPSVFNPW (in isoform 4 and isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_042699"
FT   VAR_SEQ         69..97
FT                   /note="VVSVRFEEDEDRNLCLIAYPLKGDHGIVD -> QSQRPLVSWPSLPHFFPWS
FT                   FPLWPQGSVA (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:17974005"
FT                   /id="VSP_010925"
FT   VAR_SEQ         69..87
FT                   /note="VVSVRFEEDEDRNLCLIAY -> DISSHQHGGVFVGEWGSLL (in
FT                   isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_045416"
FT   VAR_SEQ         70
FT                   /note="V -> S (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_010926"
FT   VAR_SEQ         71..426
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_010927"
FT   VAR_SEQ         88..426
FT                   /note="Missing (in isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_045417"
FT   VAR_SEQ         98..426
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:17974005"
FT                   /id="VSP_010928"
FT   VAR_SEQ         131..426
FT                   /note="Missing (in isoform 4 and isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_042700"
FT   CONFLICT        99..100
FT                   /note="VD -> AH (in Ref. 1; AAF15057)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        167
FT                   /note="G -> W (in Ref. 5; AAH65533)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   426 AA;  49186 MW;  11BDFF12C22EECFB CRC64;
     MSPAFRAMDV EPRAKGVLLE PFVHQVGGHS CVLRFNETTL CKPLVPREHQ FYETLPAEMR
     KFTPQYKGVV SVRFEEDEDR NLCLIAYPLK GDHGIVDIVD NSDCEPKSKL LRWTTNKKHH
     VLETEKTPKD WVRQHRKEEK MKSHKLEEEF EWLKKSEVLY YTVEKKGNIS SQLKHYNPWS
     MKCHQQQLQR MKENAKHRNQ YKFILLENLT SRYEVPCVLD LKMGTRQHGD DASEEKAANQ
     IRKCQQSTSA VIGVRVCGMQ VYQAGSGQLM FMNKYHGRKL SVQGFKEALF QFFHNGRYLR
     RELLGPVLKK LTELKAVLER QESYRFYSSS LLVIYDGKER PEVVLDSDAE DLEDLSEESA
     DESAGAYAYK PIGASSVDVR MIDFAHTTCR LYGEDTVVHE GQDAGYIFGL QSLIDIVTEI
     SEESGE
//
